- Obesity, diabetes and skin care treatment developer OptiBiotix Health said subsidiary ProBiotix Health had raised around £1.0 million through a note issue to help fund its separate share market listing.

Proceeds from the issue of convertible loan notes would be used to provide funding for a potential initial public offering of ProBiotix.

'This is in line with OptiBiotix's strategy announced on 5 July 2016 to form separate divisions, which could in due course become separate legal entities with the potential for a separate public listing,' the company said.

'OptiBiotix's strategy is based on its belief that the diversity of IP and commercial relationships across its four divisions reduces shareholder risk whilst offering multiple opportunities for value enhancement.'

Story provided by